Cardurion
BiotechnologyWebsite
Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. The company's therapeutics offer advanced novel mechanisms to develop new treatments for heart diseases, causing mor...
Valuation
$760M
Market implied
Share Price
N/A
Total Raised
$621.8M
Last Round
Later Stage VC (Series B)
Jul 2024
Latest Funding Round
Later Stage VC (Series B)
Jul 10, 2024
$260M
raised
Investors
+16 other investors